Benecard and DecisionRX Partner to Improve Pharmacy Benefits with Personalized Medication Insights

Benecard and DecisionRX Formed a Partnership to Enhance Pharmacy Benefits

Announcement

DecisionRX, Inc., a key player in medication therapy optimization (MTO), and Benecard PBF, the original pharmacy benefit facilitator (PBF), entered into a strategic partnership initiated to introduce personalized, data-fueled medication insights to the clients and members of Benecard PBF globally. By integrating decisionRX, Inc.’s analytics platform and advanced pharmacogenomics with Benecard PBF’s outcome-driven visible PBF model, this partnership is dedicated to enhancing health outcomes, reducing medication failure, and creating savings for health plans and employers.

Partnership key focus

Under this partnership, both companies will make equivalent contributions. The decisionRX’s MTO solution accelerates clinical pharmacists, prescription intelligence, and genomic data to validate effectiveness, safety, and personalization in therapies. The Benecard has raised its standard in pharmacy benefits. Apart from managing pharmacy benefits, it has provided a better experience. It undergoes a member-first philosophy and an auditable pricing model to align easily with decisionRX’s secured and value-based clinical approach.

The two industries will enable the same risk share and value-based options for sponsor planning. Also, confirming that the financial incentives are directly aligned with measured improvements in cost savings and health outcomes. This partnership is beneficial for clients and members. The advanced medication guidance allows patients and providers to receive accurate guidance on genomic and claimed data, decreasing trial-and-error prescribing possibilities and enhancing therapeutic efficacy.

The decisionRX’s MTO model is capable of lowering the annual cost of care by $1,200 for under-65 enrollees and $3,600 per medicare patient. The transparency between services and clients is a highlight of this partnership.

Views and Statements

President of Benecard PBF, Jeff Shea, said, “At Benecard PBF, we’ve invested our belief in the power of pharmacogenomics from the beginning. Being the early adopters, we are aware of its potential to care. This partnership is an advanced built-up. It is beyond testing; it is a conversion of insights into evidence-driven, real-time action. Being a pharmacy benefit facilitator is not just about managing benefits, but about facilitating a better health outcome. With this evolving approach, which will lead to successful results, we’re excited to provide our clients and their members the full proof care.”

Co-founder and President of DecisionRX, Travis Morgan, said, “We are delighted by this opportunity that will impact the lives of Benecard PBF’s members via our MTO platform. Benecard is well aware of the fact that medication therapy optimization is more than just cost management.”